Advertisement

Topics

John Snisarenko named Shire’s group vice president, head of ophthalmics

14:00 EDT 20 Jun 2017 | Healio

Shire has named John Snisarenko as its new group vice president and head of ophthalmics in the Unites States, according to company correspondence. Snisarenko, who most recently served as vice president of sales and marketing for Genentech’s rheumatology franchise, has 30 years of experience in the pharmaceutical, biotech and medical device industries. He has also held positions at Novartis Pharma Canada, Ciba Vision, Novadaq Technologies, Alcon Canada and Allergan Canada.

Original Article: John Snisarenko named Shire’s group vice president, head of ophthalmics

NEXT ARTICLE

More From BioPortfolio on "John Snisarenko named Shire’s group vice president, head of ophthalmics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...